DCF — ST. MARY MEDICAL CENTER
Enterprise Value: $74.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$74.2M
Enterprise Value
$18.9M
PV of Cash Flows
$55.3M
PV of Terminal Value
$89.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $119.9M | $10.2M | 8.0% | $3.3M | $3.0M |
| Year 2 | $123.5M | $11.7M | 9.0% | $4.3M | $3.6M |
| Year 3 | $127.2M | $13.4M | 10.0% | $5.4M | $4.1M |
| Year 4 | $131.0M | $14.4M | 11.0% | $6.1M | $4.2M |
| Year 5 | $134.9M | $15.2M | 11.0% | $6.5M | $4.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $74.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$116.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999862541896
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5